Patrick Gille is an Access Professional at UCB, specializing in global strategic pricing for rare diseases. They have a strong background in healthcare, focusing on tailored personalized medicine and market access disciplines including HTA and pricing negotiations. Patrick's previous roles at UCB include Head of Access Strategy for Neurology and EU Access Solution Lead for Ultra Rare Diseases. They hold an Executive MBA from Esade and have completed various advanced management courses across prestigious institutions such as Harvard Business School and the Massachusetts Institute of Technology, equipping them to inspire change and lead innovative projects within the healthcare sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices